Sever Pharma Solutions
Ulrike Foley is currently the Head of Global Business Development & Marketing at Sever Pharma Solutions, overseeing initiatives related to Hot Melt Extrusion, Injection Molding, and Highly Potent APIs. Prior to this role, Ulrike served as VP of Business Development Strategic Accounts at Adare Pharma Solutions, focusing on technology transfer and commercial manufacturing, and also held the position of VP, Head of North American Business Development at Frontida BioPharm, Inc., providing support to biopharmaceutical companies. Additional experience includes the role of Director of Global Business Development at Avara Pharmaceutical Services, where the focus was on API and DP manufacturing. Ulrike has contributed to various professional capacities, including membership in a chief organization from May 2022 to March 2025.
Previous companies
This person is not in any teams
This person is not in any offices
Sever Pharma Solutions
Sever Pharma Solutions brings your pharmaceutical ideas to life by offering expertise in high potent drug development, a drive to enhance performance, a passion for perfection, and a commitment to be your partner through the whole journey. We add value through the entire development and manufacturing processes with in-depth analytics, expertise in high potent drugs and polymer-based drug delivery systems, comprehensive material options, and creative solutions. By providing a complete value chain, from development to sourcing and worldwide commercial supply, we can offer you an optimized end-to-end solution. And as a committed long-term partner with a strong focus on creating a commercial product, we put all our resources at work for you to the finishing line – and beyond. Together with our global GMP compliance, regulatory services, and market access strategies, we can secure that your products will benefit patients all over the world.